InAADR

Protein Information

Protein Name: L-lactate dehydrogenase (P00338)
Gene Name: LDHA
Description: L-lactate dehydrogenase A chain (EC 1 1 1 27) (LDH-A) (LDH muscle subunit) (LDH-M) (Proliferation-inducing gene 19 protein)
PDB ID: 1I10
Protein Family:
Protein Category: Enzyme

This panel provides drug-protein interaction and their ADRs along with references

Interacting Drugs Toxicity Mechanism Reference
Adenosine, deoxyadenosine and deoxyguanosine Cell Lysis The inhibition of DNA cleavage was accompanied by a reduction in lactate dehydrogenase release, suggesting a causal relationship between DNA cleavage and cell death [ ADR Type 2 3 ] Adenosine, deoxyadenosine, and deoxyguanosine induce DNA cleavage in mouse thymocytes
Adenosine, deoxyadenosine and deoxyguanosine Thymocyte Deletion The inhibition of DNA cleavage was accompanied by a reduction in lactate dehydrogenase release, suggesting a causal relationship between DNA cleavage and cell death [ ADR Type 2 3 ] Adenosine, deoxyadenosine, and deoxyguanosine induce DNA cleavage in mouse thymocytes
Chlorpromazine Hepatotoxicity A toxic dose of the drug (LD20)produced elevated serum glutamate-pyruvate transaminase and lactate dehydrogenase activities 20-24 hr after drug administration,which leads to hepatotoxicity of acetaminophen in neonatal and young rats. [ ADR Type 1 ] Hepatotoxicity of acetaminophen in neonatal and young rats I Age-related changes in susceptibility
Cisplatin Nephrotoxicity Cisplatin increased urinary excretion of LDH (six-fold), GGT (twofold), and NAG (twofold); CI-973 and carboplatin increased GGT excretion (approximately twofold),which produced marked nephrotoxicity as determined by biochemical, functional, and histopathologic endpoints [ ADR Type 2 ] Comparative nephrotoxicity of a novel platinum compound, cisplatin, and carboplatin in male
Tobramycin Nephrotoxicity Treatment with TOB alone resulted in marked increases in the activities of lactate dehydrogenase,which leads to Effect of latamoxef (LMOX) against tobramycin (TOB)-induced nephrotoxicity. [ ADR Type 2 ] Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects (3) Protective effect of latamoxef against tobramycin nephrotoxicity and its protective mechanism

This panel provides information on drug category

Toxicity Source

InAADR: Drug-Protein-ADRs database